BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35757860)

  • 1. Liver function tests in primary care provide a key opportunity to diagnose and engage patients with hepatitis C.
    McLeod A; Hutchinson SJ; Weir A; Barclay S; Schofield J; Frew CG; Goldberg DJ; Heydtmann M; Wilson-Davies E
    Epidemiol Infect; 2022 Jun; 150():e133. PubMed ID: 35757860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.
    Wang AE; Hsieh E; Turner BJ; Terrault N
    J Gen Intern Med; 2022 Oct; 37(13):3435-3443. PubMed ID: 35484367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study.
    McLeod A; Hutchinson SJ; Smith S; Leen C; Clifford S; McAuley A; Wallace LA; Barclay ST; Bramley P; Dillon JF; Fraser A; Gunson RN; Hayes PC; Kennedy N; Peters E; Templeton K; Goldberg DJ
    HIV Med; 2021 May; 22(5):334-345. PubMed ID: 33350049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.
    Marukutira T; Moore KP; Hellard M; Richmond J; Turner K; Pedrana AE; Melody S; Johnston FH; Owen L; Van Den Boom W; Scott N; Thompson A; Iser D; Spelman T; Veitch M; Stoové MA; Doyle J
    BMJ Open; 2022 Mar; 12(3):e056120. PubMed ID: 35338062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C.
    Martinello M; Solomon SS; Terrault NA; Dore GJ
    Lancet; 2023 Sep; 402(10407):1085-1096. PubMed ID: 37741678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis.
    Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Valencia BM; Bajis S; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
    Lancet Gastroenterol Hepatol; 2022 May; 7(5):426-445. PubMed ID: 35303490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of hepatitis C virus infection.
    Roudot-Thoraval F
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101596. PubMed ID: 33610022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planning the hepatitis C virus elimination in Cyprus: A modeling study.
    Gountas I; Yiasemi I; Kyprianou E; Mina C; Georgiou C; Katsioloudes P; Kouroufexi A; Demetriou A; Xenofontos E; Nikolopoulos G
    World J Gastroenterol; 2021 Aug; 27(31):5219-5231. PubMed ID: 34497446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015-2021.
    Ceccarelli L; Moretti G; Mazzilli S; Petri D; Corazza I; Rizzo C; Lucenteforte E; Vainieri M; Seghieri C; Tavoschi L;
    BMC Infect Dis; 2024 Mar; 24(1):362. PubMed ID: 38553731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Securing sustainable funding for viral hepatitis elimination plans.
    Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
    Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal.
    Lin YC; Chiu WN; Chang TS; Huang TJ; Chen MY
    J Nurs Scholarsh; 2020 Mar; 52(2):128-135. PubMed ID: 31750620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis.
    Türkoğlu E; Parlak Z; Barut HŞ
    Turk J Med Sci; 2022 Dec; 52(6):1984-1990. PubMed ID: 36945985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019.
    Lee Wilkinson A; Pedrana A; Traeger MW; Asselin J; El-Hayek C; Nguyen L; Polkinghorne V; Doyle JS; Thompson AJ; Howell J; Scott N; Dimech W; Guy R; Hellard M; Stoové M;
    Epidemiol Infect; 2021 Dec; 150():e7. PubMed ID: 35249577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C: Standard of Treatment and What to Do for Global Elimination.
    Di Marco L; La Mantia C; Di Marco V
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy.
    Lazarus JV; Picchio CA; Guy D; Aleman S; James C; Nava FA; Øvrehus A; Turnes J; Ward JW; Ustianowski A
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101564. PubMed ID: 33740477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Securing wider EU commitment to the elimination of hepatitis C virus.
    Wedemeyer H; Tergast TL; Lazarus JV; Razavi H; Bakoyannis K; Baptista-Leite R; Bartoli M; Bruggmann P; Buşoi CS; Buti M; Carballo M; Castera L; Colombo M; Coutinho RS; Dadon Y; Esmat G; Esteban R; Farran JC; Gillyon-Powell M; Goldberg D; Hutchinson S; Janssen HLA; Kalamitsis G; Kondili LA; Lambert JS; Marinho RT; Maticic M; Patricello A; Peck-Radosavljevic M; Pol S; Poljak M; Pop C; Sokol T; Sypsa V; Tözün N; Younossi Z; Aghemo A; Papatheodoridis GV; Hatzakis A
    Liver Int; 2023 Feb; 43(2):276-291. PubMed ID: 36196744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination.
    Fernández-García CE; Gallego-Galiana J; Solís-Muñoz PA; Del Pozo-Maroto E; Domínguez-Alcón L; Tobar-Izquierdo M; Sáez A; Rodríguez de Cía J; Magaña-Sánchez A; Real-Martínez Y; García-Buey L; González-Moreno L; Caldas-Álvarez M; Cardeñoso-Domingo LM; González-Gamarra A; Salvador-Calvo A; González-Rodríguez Á; García-Monzón C
    Infect Dis Now; 2024 Mar; 54(2):104855. PubMed ID: 38309646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.